Portfolio company
Shift Bioscience
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops cellular rejuvenation therapeutics and an AI-driven discovery platform for pharmaceutical researchers to treat age-related diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Integrated Biosciences
The company develops small-molecule therapies for age-related diseases using a synthetic biology and machine learning platform to target cellular stress responses.
Altos Labs
This biotechnology company develops cellular rejuvenation therapies to restore cell health and reverse diseases for patients with chronic illnesses and age-related disabilities.
Gordian Biotechnology
This company develops an in vivo drug discovery platform to identify therapies for age-related diseases for the pharmaceutical and healthcare sectors.
Gero
This company develops an artificial intelligence drug discovery platform to identify therapeutic targets for chronic and age-related diseases for pharmaceutical partners.
clock.bio
This biotechnology company develops regenerative therapies for patients with age-related diseases by using gene-editing technology to decode cellular rejuvenation programs in human stem cells.
NewLimit
This biotechnology company develops epigenetic reprogramming medicines to restore cellular function and treat age-related diseases for patients.
BioAge Labs
This company develops therapeutic drugs targeting the biology of human aging to treat patients with metabolic and cardiovascular diseases.
Cambrian Biopharma
The company develops therapeutics targeting biological drivers of aging and chronic diseases for pharmaceutical partners, healthcare providers and patients.
